Business Development Manager, Smithers Information Division
United StatesContact Sean
The Future of Tissue Engineering and Cell Therapy to 2028 is based on extensive primary and secondary research frommultiple information sources. Primary research consisted of surveys and interviews with marketing/sales executives and other
senior management at tissue engineering and cell therapy companies, clinicians in this field and other stakeholders (regulatory, reimbursement, investment) in this industry. Secondary research was compiled using industry data such as company marketing literature, company annual reports, regulatory filings, peer-reviewed clinical publications, investment reports and others. Statistical data from government and non-government sources was also used to compile this report as well as published coverage policies by major third-party players.
Name The Future of Tissue Engineering & Cell Therapy Markets to 2028